231 related articles for article (PubMed ID: 11794823)
21. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
[TBL] [Abstract][Full Text] [Related]
22. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
23. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
Denke MA
Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
[TBL] [Abstract][Full Text] [Related]
24. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Eriksson M; Hådell K; Holme I; Walldius G; Kjellström T
J Intern Med; 1998 May; 243(5):373-80. PubMed ID: 9651560
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.
Carlsson CM; Papcke-Benson K; Carnes M; McBride PE; Stein JH
Drugs Aging; 2002; 19(10):793-805. PubMed ID: 12390056
[TBL] [Abstract][Full Text] [Related]
26. Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
Bak AA; Huizer J; Leijten PA; Rila H; Grobbee DE
J Intern Med; 1998 Nov; 244(5):371-8. PubMed ID: 9845852
[TBL] [Abstract][Full Text] [Related]
27. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
Sbarouni E; Kyriakides ZS; Kremastinos DTh
J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
[TBL] [Abstract][Full Text] [Related]
28. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
30. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
Jacotot B; Benghozi R; Pfister P; Holmes D
Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia.
Chan P; Tomlinson B; Lee CB; Lee YS
J Clin Pharmacol; 1996 May; 36(5):422-7. PubMed ID: 8739021
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic study of statin therapy and cholesterol reduction.
Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
[TBL] [Abstract][Full Text] [Related]
33. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
[TBL] [Abstract][Full Text] [Related]
34. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
Blasetto JW; Stein EA; Brown WV; Chitra R; Raza A
Am J Cardiol; 2003 Mar; 91(5A):3C-10C; discussion 10C. PubMed ID: 12646336
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects. A double blind test.
Saito Y; Goto Y; Nakaya N; Hata Y; Homma Y; Naito C; Hayashi H; Ito H; Yamamoto M; Takeuchi I
Atherosclerosis; 1988 Aug; 72(2-3):205-11. PubMed ID: 3145746
[TBL] [Abstract][Full Text] [Related]
38. A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE).
Ito H; Ouchi Y; Ohashi Y; Saito Y; Ishikawa T; Nakamura H; Orimo H
J Atheroscler Thromb; 2001; 8(2):33-44. PubMed ID: 11770708
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.
Hunninghake DB; Mellies MJ; Goldberg AC; Kuo PT; Kostis JB; Schrott HG; Insull W; Pan HY
Atherosclerosis; 1990 Dec; 85(2-3):219-27. PubMed ID: 2129319
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
Isaacsohn J; Insull W; Stein E; Kwiterovich P; Patrick MA; Brazg R; Dujovne CA; Shan M; Shugrue-Crowley E; Ripa S; Tota R;
Clin Cardiol; 2001 Sep; 24(9 Suppl):IV1-9. PubMed ID: 11594407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
